
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : National Science Foundation
Deal Size : $0.2 million
Deal Type : Funding
Eascra Biotech Receives U.S. National Science Foundation Grant
Details : The funding aims to conduct research and development of RNA therapeutics to advance drug delivery systems capable of effectively targeting solid tumors.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 21, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : National Science Foundation
Deal Size : $0.2 million
Deal Type : Funding
